Taken together, TRZ attenuates the detrimental effects of T2D and obesity on the development and progression of AD by mitigating chronic hyperglycemia in T2D and reducing body weight in obesity
The difference almost never comes down to the compound itself
Certain clinical situations warrant complete alcohol abstinence for patients taking tirzepatide
A licensed healthcare provider reviews your medical history, weight-loss goals, medications, BMI, and other health factors to determine whether Tirzepatide, Zepbound, or another treatment option may be appropriate
The SURMOUNT-4 trial data shows that stopping tirzepatide entirely leads to significant weight regain, so maintaining some level of medication support, even at reduced doses, appears to produce better long-term outcomes than complete cessation